What is Fathom?
Founded in 2016 and headquartered in San Francisco, Fathom operates at the intersection of healthcare and artificial intelligence. The company provides a sophisticated medical coding automation platform that utilizes deep learning to interpret clinical documentation and assign accurate medical codes. This technology is essential for modern healthcare systems, as it reduces the manual burden on medical coders, minimizes billing errors, and optimizes revenue cycle management. By automating these high-stakes administrative tasks, Fathom enables healthcare providers to focus on patient care while ensuring financial compliance and operational precision. Its market position is bolstered by a robust suite of integrations that allow it to function seamlessly within existing electronic health record environments.
How much funding has Fathom raised?
Fathom has raised a total of $46.1M across 2 funding rounds:
Debt
$150K
Series B
$46M
Debt (2020): $150K with participation from PPP
Series B (2022): $46M led by Vituity’s Inflect Health, Alkeon Capital, Lightspeed Venture Partners, and Cedars-Sinai
Key Investors in Fathom
Alkeon Capital
Alkeon Capital Management is a venture capital firm with over two decades of experience investing in transformative companies throughout their lifecycle, focusing on growth and innovation across multiple sectors.
Lightspeed Venture Partners
Lightspeed Venture Partners is a global multistage venture capital firm that invests in early and growth-stage technology companies across sectors such as enterprise software, fintech, and infrastructure.
Cedars-Sinai
Cedars-Sinai is a non-profit academic medical center that provides specialized treatments and clinical programs, serving as a strategic partner for healthtech innovation.
What's next for Fathom?
Looking ahead, Fathom is poised to leverage its recent capital to deepen its penetration into the enterprise healthcare market. The strategic focus will likely center on enhancing the platform's natural language processing capabilities to handle increasingly complex clinical scenarios. Furthermore, the company is expected to expand its partnerships with large-scale medical networks, utilizing the expertise of its diverse investor base to navigate the regulatory and operational nuances of the U.S. healthcare system. As the demand for automated revenue cycle solutions continues to rise, Fathom's ability to demonstrate measurable ROI through reduced administrative overhead will be the primary driver of its long-term growth and potential market dominance.
See full Fathom company page
